Akamis Bio logo

Akamis Bio

Harnessing the Power of Tumor Gene Therapy to Turn the Tide in the Battle Against Cancer

50 employees · est. 2010 · Abingdon, United Kingdom

VS
Apexigen logo

Apexigen

Creating Transformative Immunotherapies for Patients with Cancer

11 employees · est. 2010 · San Carlos, United States

Side-by-Side Comparison

Akamis Bio Apexigen
Founded
2010 2010
Headquarters
Abingdon, United Kingdom San Carlos, United States
Employees
50 11
Industry
Biotechnology, Health Care, Health and Wellness Biopharma, Biotechnology, Health Care
Funding Stage
Convertible Note Post Ipo Equity
Total Funding
$102.70M $175.80M
Funding Rounds
9 6
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Not tracked yet Biopharmaceutical Company, Clinical-stage, Antibody Therapeutics, Immunotherapy, Cancer Treatment, Immuno-oncology, Sotigalimab, Phase 2 Clinical Development, Immune-activating Antibody, CD40, Cancer Immunotherapy, Oncology Drug Candidate
Website
akamisbio.com apexigen.com
Akamis Bio logo

About Akamis Bio

Akamis Bio is a biotechnology company founded in 2010. Specializing in the Biotechnology and Health Care industries, it has received a significant $30.00M investment through a Convertible Note investment in 05 January 2023. This investment comes from reputable investors such as Arch Venture Partners...

Apexigen logo

About Apexigen

Apexigen is a clinical-stage biopharmaceutical company founded in 2010 with a focus on creating transformative immunotherapies for patients with cancer. The company is dedicated to discovering and developing a new generation of antibody therapeutics for the treatment of cancer, particularly emphasiz...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Akamis Bio and Apexigen — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Akamis Bio and Apexigen — by email.

Frequently Asked Questions

Akamis Bio — Harnessing the Power of Tumor Gene Therapy to Turn the Tide in the Battle Against Cancer. Apexigen — Creating Transformative Immunotherapies for Patients with Cancer . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Akamis Bio has raised $102.70M while Apexigen has raised $175.80M.
Akamis Bio and Apexigen operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Akamis Bio with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy